Surgeons Complete First Procedures Across the U.S. Utilizing Medtronic's Midas Rex Drills and Navigated Disc Prep and Interbodies with the Mazor Robotic Guidance System

Dr. Gregory Poulter of OrthoIndy , Dr. Sharad Rajpal of Boulder Neurosurgical & Spine Associates and Dr. Eiman Shafa of Twin Cities Spine Center Are First in the U.S. to Complete Surgeries Using the Most Comprehensive Integrated Spine Surgery Platform Available

- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that leading spine surgeons across the U.S. have successfully performed minimally invasive spinal procedures utilizing the newly cleared navigated disc prep, interbodies and Midas Rex™ high speed drills with the Mazor™ Robotic Guidance System. These recent surgeries mark the next step in the transformation of spine surgery as a result of the increased precision and minimally invasive technique.

These cases demonstrated the improved disc-prep access and interbody navigation, precise drilling, and predictable planning that surgeons expect from the Mazor Robotic Guidance System.

  • Dr. Gregory Poulter of OrthoIndy: Performed his first case on a 50-year-old male, a general manager at a construction company who presented with a pinched nerve in his lower back and severe leg pain. Dr. Poulter was able to conduct an OLIF360 sm Single Position Surgery and discharge the patient the following day.
  • Dr. Sharad Rajpal of Boulder Neurosurgical & Spine Associates: Conducted his first surgery at Centura-Avista Adventist Hospital using the integrated technology on an 83-year-old male, retired atmospheric physicist suffering from back and severe progressive leg pain and weakness that prevented him from walking. Dr. Rajpal performed an L2/3 decompression fusion and TLIF (Transforaminal Lumbar Interbody Fusion) on the patient, who has been discharged from the hospital and is home recovering with minimal pain and improved functionally.
  • Dr. Eiman Shafa of Twin Cities Spine Center: Completed his first minimally invasive TLIF with bilateral instrumentation using expandable interbody technology on a 36-year-old male, boiler operator/maintenance technician with back and severe left lower extremity pain and progressive weakness. The patient was observed overnight and discharged the morning after his surgery. The morning post-surgery, the patient's radicular leg pain and motor examination had returned to normal.

"Robotic assistance has fundamentally changed how we as spinal surgeons operate," said Dr. Poulter. "I believe in the benefits of robotics such that I would strongly recommend it to all of my friends or family if they are in need of a lumbar spine procedure, as I see this as potentially life-changing."

Despite elective surgery shutdowns due to the COVID-19 pandemic, many spinal procedures have continued, deemed essential due to the severity of the patient's disability.

"I believe this technology allows surgeons to perform their spinal procedures even better through more concise planning and execution in the operating room," said Dr. Rajpal. "One additional advantage is the versatility of the system. Surgeons can easily integrate the Mazor Robotic Guidance System into their current workflows - whether it's using a pre-operative planning CT with intraoperative fluoroscopy or using an O-arm™ for scanning and planning altogether in the operating room. The newest software update and instrumentation sets have also significantly improved the workflow, providing a more intuitive interface for surgeons during the planning phase, to more streamlined steps when executing the surgical plan."

"We want to congratulate each of these surgeons – and their patients – on successful procedures and recoveries," said Linnea Burman , vice president and general manager, Enabling Technologies: Cranial & Spinal Technologies, which is reported as part of the Restorative Therapies Group at Medtronic. "We continuously strive to improve the robotic surgery field, and hearing about these great success stories and how these patients' lives have been affected gives our team more motivation to achieve the next level of advancement."

About Medtronic
Medtronic plc ( www.medtronic.com ), headquartered in Dublin, Ireland , is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:




David T. Young

Ryan Weispfenning

Public Relations

Investor Relations

+1-774-284-2746

+1-763-505-4626

Medtronic plc (PRNewsfoto/Medtronic plc)

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/surgeons-complete-first-procedures-across-the-us-utilizing-medtronics-midas-rex-drills-and-navigated-disc-prep-and-interbodies-with-the-mazor-robotic-guidance-system-301228645.html

SOURCE Medtronic plc

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians.

BlinkLab states in its Wednesday (March 12) release that the study is the largest digital diagnostic trial for autism in the US, with its aim being to support the early detection of developmental conditions like autism.

The first patient test took place at PriMED Clinical Research in Dayton, Ohio. PriMED, a division of PriMED Physicians, is one of two clinical sites selected for the study’s initial phase, which is targeting 100 patients.

Keep reading...Show less
HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Limited (ASX: HMD), a medical data and technology company leading the digital transformation of maternity care, is delighted to announce it has entered into a collaboration agreement with Garmin (NYSE: GRMN), a leading global provider of smartwatches and GPS-enabled products, aimed at enhancing remote pregnancy monitoring and expanding the range of health data available to expectant mothers and their healthcare providers.

Keep reading...Show less
Cardiologist wearing virtual reality glasses.

2 Biggest Medical Device ETFs in 2025

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.

Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or a mix of both. Aside from stocks, some ETFs also track commodities or bonds.

In the healthcare industry, medical device ETFs bring together companies that go to great lengths to develop pharmaceutical-based technology that can improve the lives of patients.

Keep reading...Show less
Cyclomedica

Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the deployment of Technegas® in up to 169 nuclear medicine departments across HCA’s extensive network.1

Keep reading...Show less
CONNEQT App Launches in USA as Pulse Deliveries Commence

CONNEQT App Launches in USA as Pulse Deliveries Commence

Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries Commence

Download the PDF here.

Female doctor with clipboard talking to smiling female patient at hospital.

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both transformative medical advancements and compelling investment opportunities.

The groundbreaking developments in antifungal treatments specifically targeting women's health issues present a substantial market potential, resulting in rising investor interest in this rapidly evolving sector.

Despite comprising half the global population, women face unique health challenges that have historically received insufficient attention and investment. Among these health challenges, vaginal candidiasis stands out as a persistent and widespread issue affecting millions of women worldwide.

Keep reading...Show less

Latest Press Releases

Related News

×